ENDRA Life Sciences (NDRA) Tops Q3 EPS by 1c

ENDRA Life Sciences (NASDAQ: NDRA) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
• Premarket movers: Xenon sinks on trial pause, Netflix hit by downgrade